Voyager Therapeutics is trading 5.4% down now at $2.71 after broader risk-off trading pressured biotechnology and growth stocks.
- The decline appears tied primarily to weaker major indexes, higher Treasury yields, crude-oil inflation concerns, and a 2.04% biotechnology-sector drop.
- No company-specific announcement dated September 24, 2026 was identified; the latest official release was a September 1 investor-conference notice.